Wat heescht "Clear"?
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
Von Willebrand Disease III (vWDIII) in Scottish Terriers is a serious inherited bleeding disorder caused by a deficiency of von Willebrand factor. DNA testing for vWDIII helps identify carriers and affected dogs, enabling responsible breeding decisions to reduce disease prevalence. Early detection through genetic screening ensures timely management and improves the quality of life for Scottish Terriers. This DNA test is essential for breeders and owners aiming to maintain healthy blood clotting function in their dogs. By using vWDIII DNA testing, you can prevent the transmission of this life-threatening condition. Protect your Scottish Terrier’s health with accurate genetic testing today. Stay informed and promote responsible breeding practices with vWDIII DNA tests.
Von Willebrand Disease Type III (vWDIII) is a severe bleeding disorder found in Scottish Terriers. It is caused by a deficiency of von Willebrand factor, a protein essential for blood clotting. DNA testing can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through genetic screening reduces the risk of passing the disease to offspring. Responsible breeding practices improve the overall health of the Scottish Terrier population.
Dësen DNA Test ass abegraff ab eisem Pack Basic - an ass och Deel vun de Pak Basic, Standard, Advanced, Complete.
View DNA Test Packs →Von Willebrand Disease (vWD) is a genetic blood disorder that affects the ability of blood to clot properly. In Scottish Terriers, vWD Type III is a particularly severe form of the disease, characterized by a significant deficiency of von Willebrand factor (vWF), a protein critical for platelet adhesion during the blood clotting process. This deficiency can lead to increased bleeding tendencies, making it vital for owners and breeders to have a comprehensive understanding of the condition.
Scottish Terriers affected by vWDIII may exhibit various clinical signs, which can vary in severity. Common symptoms include excessive bleeding from minor cuts or injuries, prolonged bleeding after surgery or dental procedures, and spontaneous bleeding episodes such as nosebleeds or bruising. In some cases, affected dogs may also show signs of anemia due to chronic blood loss, which can manifest as lethargy, weakness, and pale gums.
The diagnosis of vWDIII in Scottish Terriers typically involves a combination of clinical evaluation and laboratory testing. A veterinarian may first suspect the condition based on the dog's clinical history and bleeding tendencies. Subsequently, specific tests can be conducted to measure the levels of von Willebrand factor in the blood, confirming the diagnosis of vWD Type III.
Managing Von Willebrand Disease III in Scottish Terriers focuses on minimizing bleeding risks and addressing any episodes of excessive bleeding. Treatment options may include the use of desmopressin, a medication that can temporarily increase the levels of von Willebrand factor in the bloodstream. Additionally, owners are advised to take precautions to avoid situations that may lead to injury or bleeding, such as avoiding rough play or high-risk activities. In severe cases, blood transfusions may be necessary to manage acute bleeding episodes.
Genetic testing plays a crucial role in managing Von Willebrand Disease III in Scottish Terriers. By identifying carriers of the vWD gene, breeders can make informed decisions to minimize the risk of producing affected puppies. Responsible breeding practices, including screening potential breeding dogs for the vWD gene, can significantly reduce the prevalence of this condition in future generations.
Von Willebrand Disease III is a serious condition in Scottish Terriers that requires awareness and proactive management. By understanding the signs, diagnosis, and treatment options available, owners can better care for their dogs and contribute to responsible breeding practices that help reduce the incidence of this hereditary disorder.
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
Nee D'Déier ass allgemeng gesond mee kann d'Mutatioun un seng iwwerdroen Nofolger.
Et huet zwee mutéiert Exemplare. Klinesch Zeeche ginn erwaart jee no der Krankheet. Et soll net gefeelt ginn.
E puer Krankheeten sinn Geschlecht verbonnen, sou datt hiren Ausdrock variéiert jee no der Geschlecht vum Déier.
This DNA test detects the mutation associated with Von Willebrand Disease Iii In Scottish Terrier (vWDIII-ST) in order to identify clear, carrier, or at-risk animals.
DNA Testen hëlleft Züchter méi sécher Maten ze plangen an de Risiko ze reduzéieren fir d'Mutatioun un d'Nofolger ze iwwerdroen.
Den Ierfschaftsmodus fir dësen Test gemellt ass Autosomal Recessive.
This test analyses the mutation VWF c.255del.
Net onbedéngt. D'Interpretatioun hänkt vum Ierfschaftsmuster an dem resultéierende Genotyp of.
Venta P J, Li J, YuzbasiyanGurkan V, Brewer G J, Schall W D. Mutation causing von Willebrand's disease in Scottish Terriers. J Vet Intern Med. 2000 Jan-Feb;14(1):10-9. doi: 10.1892/0891-6640(2000)0142.3.co;2.
Är Privatsphär, Äre Choix
Mir benotze wesentlech Cookien fir d'Websäit ze lafen. Optional Cookien (wéi embedded Inhalt Provider) sinn als Standard deaktivéiert a sinn nëmmen aktivéiert wann Dir averstanen ass. Dir kënnt Äre Choix zu all Moment mat der "Cookien" Knäppchen änneren.
Néideg fir Kär Funktiounen a Sécherheet. Ëmmer aktivéiert.
Verbessert Funktiounen wéi Präferenz spueren oder Net-Reklamm Embeds.
Hëlleft eis d'Benotzung vum Site ze verstoen. Standard behënnert.
Annoncéieren / Tracking iwwer Siten (e puer Video / Kaarten embeds). Standard behënnert.